Indeed, in vitro studies stimulating PBMCs or liver infiltrating lymphocytes from patients with autoimmune liver diseases with low doses of IL-2 showed improved survival and function of Foxp3+ TREG [53]. The gene discussed is FOXP3; the disease is autoimmune hepatitis.